Azithromycin add-on therapy in high-risk postendoscopic sinus surgery patients failing corticosteroid irrigations: A clinical practice audit

American Journal of Rhinology and Allergy

Volumn 28, Issue 2, 2014, Pages 151-155

  Maniakas, Anastasios ^a   Desrosiers, Martin ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; AZITHROMYCIN; BUDESONIDE; CORTICOSTEROID; PHARMACOLOGICAL BIOMARKER;

ADD ON THERAPY; ADULT; ARTICLE; CHRONIC RHINOSINUSITIS; CLINICAL PRACTICE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENDOSCOPIC SINUS SURGERY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NASAL LAVAGE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; SURGICAL PATIENT; ADJUVANT CHEMOTHERAPY; CHRONIC DISEASE; DRUG EFFECTS; ENDOSCOPY; EVALUATION STUDY; LAVAGE; METABOLISM; PARANASAL SINUS; POSTOPERATIVE CARE; RHINITIS; RISK FACTOR; SEX DIFFERENCE; SINUSITIS; TOTAL QUALITY MANAGEMENT; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; AZITHROMYCIN; BIOMARKERS, PHARMACOLOGICAL; BUDESONIDE; CHEMOTHERAPY, ADJUVANT; CHRONIC DISEASE; CLINICAL AUDIT; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PARANASAL SINUSES; POSTOPERATIVE CARE; QUALITY IMPROVEMENT; RECURRENCE; RETROSPECTIVE STUDIES; RHINITIS; RISK FACTORS; SEX FACTORS; SINUSITIS; THERAPEUTIC IRRIGATION; TREATMENT FAILURE;

EID: 84897130062     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.4017     Document Type: Article

References (39)

1. Desrosiers MY, and Kilty SJ. Treatment alternatives for chronic rhinosinusitis persisting after ESS: What to do when antibiotics, steroids and surgery fail. Rhinology 46:3-14, 2008.
2. Anand VK. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 193:3-5, 2004. (Pubitemid 38623547)
3. Singhal D, Psaltis AJ, Foreman A, and Wormald PJ. The impact of biofilms on outcomes after endoscopic sinus surgery. Am J Rhinol Allergy 24:169-174, 2010.
4. Hochstim CJ, Masood R, and Rice DH. Biofilm and persistent inflammation in endoscopic sinus surgery. Otolaryngol Head Neck Surg 143:697-698, 2010.
5. Bendouah Z, Barbeau J, Hamad WA, and Desrosiers M. Biofilm formation by Staphylococcus aureus and Pseudomonas aeruginosa is associated with an unfavorable evolution after surgery for chronic sinusitis and nasal polyposis. Otolaryngol Head Neck Surg 134:991-996, 2006. (Pubitemid 43766544)
6. DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope 115:946-957, 2005. (Pubitemid 40776980)
7. Ozmen S, Yucel OT, Sinici I, et al. Nasal pepsin assay and pH monitoring in chronic rhinosinusitis. Laryngoscope 118:890-894, 2008. (Pubitemid 351631294)
8. Valera FCP, Scrideli C, Queinoz R, et al. NF-kappaB expression predicts clinical outcome for nasal polyposis. Rhinology 48:408-441, 2010.
9. Lund VJ, Black JH, Szabo LZ, et al. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 42:57-62, 2004. (Pubitemid 38811704)
10. Lavigne F, Cameron L, Renzi PM, et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 112:858-864, 2002. (Pubitemid 34477616)
11. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 131:S1-S62, 2004. (Pubitemid 39577605)
12. Gibson PG, Simpson JL, and Saltos N. Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest 119:1329-1336, 2001. (Pubitemid 32686012)
13. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 181:315-323, 2010.
14. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: A randomized controlled trial. JAMA 290:1749-1756, 2003. (Pubitemid 37430625)
15. Wolter J, Seeney S, Bell S, et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: A randomised trial. Thorax 57:212-216, 2002. (Pubitemid 34214405)
16. Equi AC, Davies JC, Painter H, et al. Exploring the mechanisms of macrolides in cystic fibrosis. Respir Med 100:687-697, 2006. (Pubitemid 43285757)
17. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. Antimicrob Agents Chemother 31:1939-1947, 1987. (Pubitemid 18009566)
18. Tamaoki J. The effects of macrolides on inflammatory cells. Chest 125:41S-50S, 2004.
19. Nagi MM, and Desrosiers MY. Algorithms for management of chronic rhinosinusitis. Otolaryngol Clin North Am 38:1137-1141, vii, 2005.
20. Nader ME, Abou-Jaoude P, Cabaluna M, and Desrosiers M. Using response to a standardized treatment to identify phenotypes for genetic studies of chronic rhinosinusitis. J Otolaryngol Head Neck Surg 39:69-75, 2010.
21. Steinke JW, Payne SC, Tessier ME, et al. Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis. J Allergy Clin Immunol 124:1352-1354.e1357, 2009.
22. Desrosiers M, Evans GA, Keith PK, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol 7:2, 2011.
23. Annamalai S, Davis J, and Kubba H. How subjective is nasal endoscopy? A study of interrater agreement using the Lund and Mackay scoring system. Am J Rhinol 18:301-303, 2004.
24. Equi A, Balfour-Lynn IM, Bush A, and Rosenthal M. Long term azithromycin in children with cystic fibrosis: A randomised, placebo-controlled crossover trial. Lancet 360:978-984, 2002. (Pubitemid 35284109)
25. Clement A, Tamalet A, Leroux E, et al. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. Thorax 61:895-902, 2006. (Pubitemid 44570311)
26. Baumann U, King M, App EM, et al. Long term azithromycin therapy in cystic fibrosis patients: A study on drug levels and sputum properties. Can Respir J 11:151-155, 2004.
27. Snidvongs K, Pratt E, Chin D, et al. Corticosteroid nasal irrigations after endoscopic sinus surgery in the management of chronic rhinosinusitis. Int Forum Allergy Rhinol 2:415-421, 2012.
28. Snidvongs K, Kalish L, Sacks R, et al. Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: Systematic review and meta-analysis. Am J Rhinol Allergy 27:221-233, 2013.
29. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50:1-12, 2012.
30. Plouin-Gaudon I, Clement S, Huggler E, et al. Intracellular residency is frequently associated with recurrent Staphylococcus aureus rhinosinusitis. Rhinology 44:249-254, 2006. (Pubitemid 46029235)
31. Jervis-Bardy J, Foreman A, Boase S, et al. What is the origin of Staphylococcus aureus in the early postoperative sinonasal cavity? Int Forum Allergy Rhinol 1:308-312, 2011.
32. Lee YK, and Mazmanian SK. Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330:1768-1773, 2010.
33. Cervin A, Kalm O, Sandkull P, and Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: Clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 126:481-489, 2002. (Pubitemid 41123534)
34. Hashiba M, and Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 525:73-78, 1996. (Pubitemid 26332367)
35. Haruna S, Shimada C, Ozawa M, et al. A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. Rhinology 47:66-71, 2009.
36. Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189-193, 2006. (Pubitemid 44383921)
37. Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: A randomized controlled trial. Allergy 66:1457-1468, 2011.
38. Suzuki H, Ikeda K, Honma R, et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 62:121-127, 2000. (Pubitemid 30248562)
39. Ray WA, Murray KT, Hall K, et al. Azithromycin and the risk of cardiovascular death. N Engl J Med 366:1881-1890, 2012.